Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come?

Since mesenchymal stromal/stem cells (MSCs) were discovered, researchers have been drawn to study their peculiar biological features, including their immune privileged status and their capacity to selectively migrate into inflammatory areas, including tumors. These properties make MSCs promising cel...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Giulia Golinelli, Ilenia Mastrolia, Beatrice Aramini, Valentina Masciale, Massimo Pinelli, Lucrezia Pacchioni, Giulia Casari, Massimiliano Dall’Ora, Milena Botelho Pereira Soares, Patrícia Kauanna Fonseca Damasceno, Daniela Nascimento Silva, Massimo Dominici, Giulia Grisendi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2020-09-01
Serie:Frontiers in Pharmacology
Soggetti:
mesenchymal stromal/stem cell
cancer
tumor necrosis factor-related apoptosis-inducing ligand
gene therapy
cell therapy
Accesso online:https://www.frontiersin.org/article/10.3389/fphar.2020.529921/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi